Biotech startup funding in 2026
Every new Form D round of US startups in Biotech & Pharma first filed in 2026, to Nov 20, 2026. Updated each business day.
401 biotech startups filed a new Form D round in 2026. Together they reported $5.37B sold in 451 rounds. The median round was $2.0M.
Companies
401
with a new round in 2026
Reported sold
$5.37B
451 rounds
Median round
$2.0M
rounds with an amount
Largest round
$237.5M
Pathos AI, Inc.
New funding by month
Amount reported sold in new Form D rounds, by the month each round was first filed. Hover a bar for the number of rounds.
Show as table
| Month | Rounds | Reported sold |
|---|---|---|
| November 2026 | 31 | $463.5M |
| October 2026 | 47 | $577.1M |
| September 2026 | 41 | $466.8M |
| August 2026 | 64 | $768.5M |
| July 2026 | 35 | $484.9M |
| June 2026 | 51 | $604.6M |
| May 2026 | 34 | $219.6M |
| April 2026 | 36 | $392.8M |
| March 2026 | 44 | $735.8M |
| February 2026 | 35 | $310.6M |
| January 2026 | 33 | $352.6M |
August 2026 was the largest month, at $768.5M in 64 rounds.
Biotech companies that raised the most in 2026
| # | Company | Reported sold | Rounds | Focus | Latest round |
|---|---|---|---|---|---|
| 1 | Pathos AI, Inc.Chicago, IL | $237.5M | 1 | Therapeutics | Nov 19, 2026 |
| 2 | AdvanCell, Inc.Cambridge, MA | $218.3M | 1 | Therapeutics | Jul 16, 2026 |
| 3 | Warp Sciences Inc.Portola Valley, CA | $194.6M | 1 | Life science tools and services | Oct 26, 2026 |
| 4 | Epicrispr Biotechnologies, Inc.South San Francisco, CA | $176.7M | 1 | Cell and gene therapy | Aug 26, 2026 |
| 5 | Ollin Biosciences, Inc.Austin, TX | $156.2M | 1 | Therapeutics | Jun 24, 2026 |
| 6 | SonoThera, Inc.South San Francisco, CA | $125.4M | 1 | Cell and gene therapy | Jun 30, 2026 |
| 7 | Solstice Oncology, Inc.Boston, MA | $121.2M | 1 | Therapeutics | Mar 9, 2026 |
| 8 | Rakuten Medical, Inc.San Diego, CA | $120.4M | 2 | Therapeutics | Oct 6, 2026 |
| 9 | Iliad Biotechnologies, Inc.Weston, FL | $115.5M | 1 | Therapeutics | Feb 20, 2026 |
| 10 | Strand Therapeutics Inc.Boston, MA | $108.0M | 1 | Therapeutics | Mar 17, 2026 |
| 11 | Georgiamune, Inc.Gaithersburg, MD | $92.6M | 1 | Therapeutics | Aug 17, 2026 |
| 12 | Proxima Bio, Inc.New York, NY | $91.4M | 1 | Drug discovery platforms | Jan 21, 2026 |
| 13 | Alzheon, Inc.Framingham, MA | $78.7M | 1 | Therapeutics | Sep 10, 2026 |
| 14 | Cellanome, Inc.Foster City, CA | $75.9M | 1 | Life science tools and services | Jun 22, 2026 |
| 15 | BigHat Biosciences, Inc.San Mateo, CA | $75.1M | 1 | Drug discovery platforms | Oct 26, 2026 |
| 16 | Altesa BioSciences, Inc.College Park, GA | $74.9M | 1 | Therapeutics | Feb 23, 2026 |
| 17 | EXUMA Biotech Corp.West Palm Beach, FL | $70.0M | 1 | Cell and gene therapy | Aug 20, 2026 |
| 18 | Ratio Therapeutics, Inc.Boston, MA | $69.9M | 1 | Therapeutics | Jul 31, 2026 |
| 19 | Matchpoint Therapeutics Inc.Watertown, MA | $68.3M | 1 | Therapeutics | Nov 20, 2026 |
| 20 | Integrated Biosciences, Inc.Redwood City, CA | $68.3M | 1 | Not classified yet | Aug 5, 2026 |
| 21 | Gilgamesh Pharma Inc.New York, NY | $68.3M | 4 | Therapeutics | Mar 31, 2026 |
| 22 | Superluminal Medicines, Inc.Boston, MA | $65.4M | 1 | Drug discovery platforms | Sep 3, 2026 |
| 23 | Stipple Bio, Inc.Cambridge, MA | $65.1M | 1 | Therapeutics | Apr 6, 2026 |
| 24 | AirNexis Therapeutics, Inc.Palo Alto, CA | $62.0M | 1 | Therapeutics | Mar 9, 2026 |
| 25 | Moonwalk Biosciences, Inc.South San Francisco, CA | $59.9M | 1 | Therapeutics | Sep 14, 2026 |
Largest rounds of 2026
All industries →| Company | Focus | Location | Amount sold | Investors | Filing |
|---|---|---|---|---|---|
Pathos AI, Inc.Repeat raise · November 19, 2026 | Therapeutics | Chicago, IL | $237.5M | 13 | Form D ↗ |
AdvanCell, Inc.First Form D · July 16, 2026 | Therapeutics | Cambridge, MA | $218.3M | 41 | Form D ↗ |
Warp Sciences Inc.First Form D · October 26, 2026 | Life science tools and services | Portola Valley, CA | $194.6M | 50 | Form D ↗ |
Epicrispr Biotechnologies, Inc.First Form D · August 26, 2026 | Cell and gene therapy | South San Francisco, CA | $176.7M | 47 | Form D ↗ |
Ollin Biosciences, Inc.First Form D · June 24, 2026 | Therapeutics | Austin, TX | $156.2M | 32 | Form D ↗ |
SonoThera, Inc.Repeat raise · June 30, 2026 | Cell and gene therapy | South San Francisco, CA | $125.4M | 22 | Form D ↗ |
Solstice Oncology, Inc.First Form D · March 9, 2026 | Therapeutics | Boston, MA | $121.2M | 8 | Form D ↗ |
Iliad Biotechnologies, Inc.First Form D · February 20, 2026 | Therapeutics | Weston, FL | $115.5M | 36 | Form D ↗ |
Rakuten Medical, Inc.Repeat raise · April 13, 2026 | Therapeutics | San Diego, CA | $111.5M | 26 | Form D ↗ |
Strand Therapeutics Inc.Repeat raise · March 17, 2026 | Therapeutics | Boston, MA | $108.0M | 10 | Form D ↗ |
Where these companies are
Every Biotech & Pharma round of 2026 451
All industries →How this page is built
- Which rounds. New Form D offerings of US startups in Biotech & Pharma first filed in 2026, dated by that first filing. Later amendments update an amount; they are not new rounds.
- Ranking. By the total reported sold across a company's rounds of 2026. Two SEC filers of one company, such as a holding company and its operating company, count as one company, under the name on the newest filing.
- Left out. Public companies, companies based outside the US, and mergers or spin-offs. Some companies raise money without filing a Form D.